Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.100 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.44 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
EG.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.502EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.285EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.582EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.580EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.306EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.280EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.329EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.311EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used